Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Liu, Xiaofang ^a   Xue, Yong ^a   Liu, Chunhua ^a   Lou, Qiaoming ^b   Wang, Jingfeng ^a   Yanagita, Teruyoshi ^c   Xue, Changhu ^a   Wang, Yuming ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b NINGBO UNIVERSITY   (China)

^c NISHIKYUSHU UNIVERSITY   (Japan)

Author keywords

Eicosapentaenoic acid; Insulin resistance; Lipid metabolism; Metabolic syndrome; Obesity; Phospholipid

Indexed keywords

ADIPONECTIN; EICOSAPENTAENOIC ACID ENRICHED PHOSPHOLIPID; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 6; LEPTIN; LIVER ENZYME; MESSENGER RNA; PHOSPHOLIPID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; EICOSAPENTAENOIC ACID; FATTY LIVER; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LIPID METABOLISM; LIPOGENESIS; MALE; METABOLIC SYNDROME X; MICE; MICE, OBESE; PHOSPHOLIPIDS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

MUS; ZEA MAYS;

EID: 84880335323     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-109     Document Type: Article

References (48)

1. Mechanisms linking obesity with cardiovascular disease. Van Gaal LF, Mertens IL, De Block CE, Nature 2006 444 875 880 10.1038/nature05487 17167476 (Pubitemid 46028447)
2. n-3 fatty acids and serum lipoproteins: animal studies. Harris WS, Am J Clin Nutr 1997 65 5 1611S 1616S 9129501 (Pubitemid 27187955)
3. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A, Int J Cardiol 2009 136 1 4 16 10.1016/j.ijcard.2008.03.092 18774613
4. n-3 fatty acids ans cardiovascular disease. Breslow JL, Am J Clin Nutr 2006 83 1477 1482
5. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ, Atherosclerosis 2008 197 1 12 24 10.1016/j.atherosclerosis.2007.11.008 18160071
6. The role of fish oils in the treatment of rheumatoid arthritis. Cleland LG, James MJ, Proudman SM, Drugs 2003 63 9 845 853 10.2165/00003495-200363090- 00001 12678571 (Pubitemid 36543082)
7. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. Boudrault C, Bazinet RP, Ma DW, J Nutr Biochem 2009 20 1 1 10 10.1016/j.jnutbio.2008.05.016 18824343
8. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA, EFSA J 2010 8 1461
9. Marine lipid-based liposomes increase in vivo FA bioavailability. Cansell M, Nacka F, Combe N, Lipids 2003 38 5 551 559 10.1007/s11745-003-1341-0 12880112 (Pubitemid 36760244)
10. Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [§ssup§13§esup§C]DHA in phosphatidylcholine. Lemaitre-Delaunay D, Pachiaudi C, Laville M, Pousin J, Armstrong M, Lagarde M, J Lipid Res 1999 40 1867 1874 10508206 (Pubitemid 29477257)
11. Dietary phospholipids, hepatic lipid metabolism and cardiovascular. Cohn JS, Wat E, Kamili A, Tandy S, Curr Opin Lipidol 2008 19 3 257 262 10.1097/MOL.0b013e3282ffaf96 18460916 (Pubitemid 351653563)
12. Dietary oils and phospholipids containing n-3 highly unsaturated fatty acids suppress 2,4-dinitro-1- fluorobenzene-induced contact dermatitis in mice. Morizawa KTY, Tsuchida M, Nakano Y, Hibino H, Tanaka Y, J Jpn Oil Chem Soc 2000 49 1 59 65 10.5650/jos1996.49.59
13. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. Rossmeisl M, Jilkova ZM, Kuda O, Jelenik T, Medrikova D, Stankova B, Kristinsson B, Haraldsson GG, Svensen H, Stoknes I, Sjovall P, Magnusson Y, Balvers MG, Verhoeckx KC, Tvrzicka E, Bryhn M, Kopecky J, PLoS One 2012 7 6 38834 10.1371/journal.pone.0038834 22701720
14. Effect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in mice. Hiratsuka S, Ishihara K, Kitagawa T, Wada S, Yokogoshi H, J Nutr Sci Vitaminol (Tokyo) 2008 54 6 501 506 10.3177/jnsv.54.501
15. Effects of dietary docosahexaenoic acid connecting phospholipids on the learning ability and fatty acid composition of the brain. Hiratsuka S, Koizumi K, Ooba T, Yokogoshi H, J Nutr Sci Vitaminol (Tokyo) 2009 55 4 374 380 10.3177/jnsv.55.374
16. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Sanna F, Bisogno T, Uda S, Collu M, Bruheim I, Di Marzo V, Banni S, J Nutr 2009 139 8 1495 1501 10.3945/jn.109.104844 19549757
17. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Bunea R, El Farrah K, Deutsch L, Altern Med Rev 2004 9 4 420 428 15656713 (Pubitemid 40066715)
18. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-alpha. Vigerust NF, Bjorndal B, Bohov P, Brattelid T, Svardal A, Berge RK, Eur J Nutr in press
19. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T, J Agric Food Chem 2007 55 17 7170 7176 10.1021/jf071225x 17661494 (Pubitemid 47338962)
20. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI, Lipids 2011 46 1 37 46 10.1007/s11745-010-3490-4 21042875
21. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM, Nutr Res 2009 29 9 609 615 10.1016/j.nutres.2009.09.004 19854375
22. Dietary effects of eicosapentaenoic and docosahexaenoic acid esters on lipid metabolism and immune parameters in Sprague-Dawley rats. Hung P, Gu JY, Kaku S, Yunoki S, Ohkura K, Ikeda I, Tachibana H, Sugano M, Yazawa K, Biosci Biotechnol Biochem 2000 64 12 2588 2593 10.1271/bbb.64.2588 11210121
23. Effects of three different highly purified n-3 series highly unsaturated fatty acids on lipid metabolism in C57BL/KsJ-db/db mice. Gotoh N, Nagao K, Onoda S, Shirouchi B, Furuya K, Nagai T, Mizobe H, Ichioka K, Watanabe H, Yanagita T, Wada S, J Agric Food Chem 2009 57 22 11047 11054 10.1021/jf9026553 19848389
24. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ, Circulation 2000 102 1264 1269 10.1161/01.CIR.102.11.1264 10982541
25. Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as docosahexaenoic acid but differ in inflammatory effects. Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J, Nutrition 2008 24 5 245 254 18312787 (Pubitemid 351179962)
26. A simple method for the isolation and purification of total lipids from animal tissues. Folch J, Lees M, Sloane Stanley GH, J Biol Chem 1957 226 1 497 509 13428781
27. Improved separation and quantification of neutral and polar lipid classes by HPLC-ELSD using a monolithic silica phase: application to exceptional marine lipids. Graeve M, Janssen D, J Chromatogr B 2009 877 20-21 1815 1819
28. Lipid profile and fatty acid compositions in body wall of Apostichopus Japonicus (Selenka). Lou QM, Wang YM, Liu XF, Xue CH, J Food Biochem 2012 36 3 317 321 10.1111/j.1745-4514.2011.00544.x
29. Phosphorous assay in column chromatography. Bartlett GR, J Biol Chem 1959 234 466 468 13641241
30. Protein measurement with the Folin phenol reagent. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, J Biol Chem 1951 193 265 275 14907713
31. Effect of prior nutritional status on the activity of lipogenic enzymes in primary monolayer cultures of rat hepatocytes. Kelley DS, Nelson GJ, Hunt JE, Biochem J 1986 235 1 87 90 2874793 (Pubitemid 16041976)
32. Ethanol modulation of the hormonal and nutritional regulation of glucose 6-phosphate dehydrogenase activity in primary cultures of rat hepatocytes. Kelly DS, Kletzien RF, Biochem J 1984 217 2 543 549 6365088 (Pubitemid 14178986)
33. Malic enzyme. Ochoa S, Methods in Enzymology New York, NY: Academic Press, Colowick SP, Kaplan NO, 1955 1 739 753
34. The subcellular distribution of carnitine acyltransferase in mammalian liver and kidney A new peroxisomal enzyme. Markwell MA, McGroarty EJ, Bieber LL, Tolbert NE, J Biol Chem 1973 248 3426 3432 4702872
35. Assay of Peroxisomal β-oxidation of fatty acids. Lazarow PB, Methods in Enzymology New York, NY: Academic Press, Lowenstein JM, 1981 315 319
36. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
37. Insulin resistance and lipid metabolism. Frayn KN, Curr Opin Lipidol 1993 4 3 197 204 10.1097/00041433-199306000-00004 (Pubitemid 23167085)
38. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD, Diabetes 1988 37 8 1020 1024 10.2337/diabetes.37.8.1020 3292322 (Pubitemid 19033579)
39. Adipokines in inflammation and metabolic disease. Ouchi N, Parker JL, Lugus JJ, Walsh K, Nat Rev Immunol 2011 11 2 85 97 10.1038/nri2921 21252989
40. Anti-inflammatory and anti-atherogenic properties of adiponectin. Ohashi K, Ouchi N, Matsuzawa Y, Biochimie 2012 94 10 2137 2142 10.1016/j.biochi.2012. 06.008 22713764
41. Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice. Tandy S, Chung RWS, Wat E, Kamili A, Berge K, Griinari M, Cohn JS, J Agric Food Chem 2009 57 19 9339 9345 10.1021/jf9016042 19761211
42. Control of food intake in the obese. Blundell JE, Gillett A, Obes Res 2001 9 S11 263S 270S 11707552
43. Dietary polyunsaturated fatty acids and inflammatory mediator production. James MJ, Gibson RA, Cleland LG, Am J Clin Nutr 2000 71 1 343S 348S 10617994 (Pubitemid 30046139)
44. Additive benefits of long chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinemic women. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, Jebb SA, Int J Obes (Lond) 2006 30 1535 1544 10.1038/sj.ijo. 0803309 (Pubitemid 44470203)
45. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R, Brain Behav Immun 2012 26 6 988 995 10.1016/j.bbi.2012.05.011 22640930
46. Fatty acid regulation of hepatic gene transcription. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O, J Nutr 2005 135 11 2503 2506 16251601 (Pubitemid 43156586)
47. Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl ester reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs. Froyland L, Vaagenes H, Asiedu DK, Garras A, Lie O, Berge RK, Lipids 1996 31 2 169 178 10.1007/BF02522617 8835405 (Pubitemid 26066086)
48. Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits: role of the hepato-biliary axis. Polichetti E, Janisson A, de la Porte PL, Portugal H, Leonardi J, Luna A, La Droitte P, Chanussot F, Life Sci 2000 67 21 2563 2576 10.1016/S0024-3205(00)00840-7 11104358